烟曲霉
毒力
锡尔图因
微生物学
生物
遗传学
基因
乙酰化
作者
Natália S. Wassano,Gabriela B. da Silva,Artur Honorato Reis,Jaqueline Aline Gerhardt,Everton P. Antoniel,Daniel Yuri Akiyama,Caroline Patini Rezende,Leandro Xavier Neves,Elton J. R. Vasconcelos,Fernanda Lopes de Figueiredo,Fausto Almeida,Patrícia Alves de Castro,Camila Figueiredo Pinzan,Gustavo H. Goldman,Adriana Franco Paes Leme,Taícia Pacheco Fill,Nilmar Silvio Moretti,André Damásio
标识
DOI:10.1038/s42003-024-06383-3
摘要
Abstract Aspergillus fumigatus represents a public health problem due to the high mortality rate in immunosuppressed patients and the emergence of antifungal-resistant isolates. Protein acetylation is a crucial post-translational modification that controls gene expression and biological processes. The strategic manipulation of enzymes involved in protein acetylation has emerged as a promising therapeutic approach for addressing fungal infections. Sirtuins, NAD + -dependent lysine deacetylases, regulate protein acetylation and gene expression in eukaryotes. However, their role in the human pathogenic fungus A. fumigatus remains unclear. This study constructs six single knockout strains of A. fumigatus and a strain lacking all predicted sirtuins (SIRTKO). The mutant strains are viable under laboratory conditions, indicating that sirtuins are not essential genes. Phenotypic assays suggest sirtuins’ involvement in cell wall integrity, secondary metabolite production, thermotolerance, and virulence. Deletion of sirE attenuates virulence in murine and Galleria mellonella infection models. The absence of SirE alters the acetylation status of proteins, including histones and non-histones, and triggers significant changes in the expression of genes associated with secondary metabolism, cell wall biosynthesis, and virulence factors. These findings encourage testing sirtuin inhibitors as potential therapeutic strategies to combat A. fumigatus infections or in combination therapy with available antifungals.
科研通智能强力驱动
Strongly Powered by AbleSci AI